Loading...

NUVB NUVATION BIO INC Capital Structure Changes 8-K Filing

NVTN

NVB

NUVATION BIO INC

(NUVB)

2025 8-K

Show Summary

Show Summary

Pre-Market Approval

Financial Statements

Supply Agreement

Financial Results

Supply Agreement

Loan Agreements

Financial Results

CFO Appointment

Annual Meeting Results

Financial Results Announcement

Financial Results Announcement

Acquisition Completed

Merger Agreement

Financial Results Announcement

Appointment of Director

Resignation of Director

Financial Results Announcement

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Earnings Reports

Petition for Resolution of ...

External Links:

On March 3, 2025, Nuvation Bio Inc. secured a $100 million senior secured loan and a $150 million revenue interest financing agreement to fund the development of taletrectinib, with specific repayment terms and conditions outlined.

AI Assistant

NUVATION BIO INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.